Editors' Pick Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis. Kalincik T, Spelman T, Trojano M, Duquette P, Izquierdo G, Grammond P, Lugaresi A, Hupperts R, Cristiano E, van Pesch V, et al. PLoS One. 2013; 8(5):e63480. Epub 2013 May 21. PMID: 23704913. Abstract CommentRecommendBookmarkWatch